Combating antibiotic resistance – A Policy Roadmap to Reduce Use of Medically Important Antibiotics in Livestock. Report from the Expert Commission on Addressing the Contribution of Livestock to the Antibiotic Resistance Crisis 2017.
On 24 August, the Access to Medicine Foundation published the methodology for its 2018 Antimicrobial Resistance Benchmark. It is the first independently developed framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance (AMR). The framework was developed through consultation with stakeholders and experts working in AMR to build consensus on the priorities for pharmaceutical companies in AMR.
This summer, the European Commission adopted a new Action Plan to tackle Antimicrobial Resistance (AMR) – a growing threat that is responsible for 25,000 deaths and a loss of €1.5 billion in the EU every year.
Press release: IMI launches €130m Calls for proposals with focus on Alzheimer’s, big data, vaccines, & more
Today, the Innovative Medicines Initiative (IMI) is launching two new Calls for proposals with topics on Alzheimer’s disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results.
During the NADP launch event, we asked the scientific and business community to provide input on the aims and activities planned for NADP. What should NADP do for you?
Kees de Joncheere, chair of the NADP Executive Board and former Director of the Essential Medicines and Health Products Department at the World Health Organisation (WHO) is focused on the international opportunities for NADP. Over the last years increasing concern has been expressed at the international level over the threat of antimicrobial resistance, leading to the adoption of the Global Action Plan on AMR by the WHO World Health Assembly, and the UN General Assembly resolution on AMR in 2016.